Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods of use thereof

Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods of use thereof

US Patent 11633476 · Granted Apr 25, 2023

Estimated economic value: $617,771,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Solution formulations of engineered anti-IL-23p19 antibodies2025
Interpreting color in an environment2025
Activity based sorting in collaborative applications2025
Graphics projector for use in a vehicle2025
Risk informed route planner2025
Holographic display calibration2025
Anti-naloxone and anti-naltrexone monoclonal antibodies and methods of productio2025
Co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies2025
Cement composition containing an oil ash set retarder2022
Sandwich assay design for small molecules2022
Crystals of anti-human PD-1 monoclonal antibodies2021
High performance concretes and methods of making thereof2021